Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Chemogenomic profiling predicts antifungal synergies.

Jansen G, Lee AY, Epp E, Fredette A, Surprenant J, Harcus D, Scott M, Tan E, Nishimura T, Whiteway M, Hallett M, Thomas DY.

Mol Syst Biol. 2009;5:338. doi: 10.1038/msb.2009.95. Epub 2009 Dec 22.

2.

Reverse genetics in Candida albicans predicts ARF cycling is essential for drug resistance and virulence.

Epp E, Vanier G, Harcus D, Lee AY, Jansen G, Hallett M, Sheppard DC, Thomas DY, Munro CA, Mullick A, Whiteway M.

PLoS Pathog. 2010 Feb 5;6(2):e1000753. doi: 10.1371/journal.ppat.1000753.

3.

Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates.

Youngsaye W, Vincent B, Hartland CL, Morgan BJ, Buhrlage SJ, Johnston S, Bittker JA, MacPherson L, Dandapani S, Palmer M, Whitesell L, Lindquist S, Schreiber SL, Munoz B.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5502-5. doi: 10.1016/j.bmcl.2011.06.105. Epub 2011 Jun 30.

4.

Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.

Pancholi P, Park S, Perlin D, Kubin C, Della-Latta P.

J Clin Microbiol. 2004 Dec;42(12):5938-9.

5.

Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans.

Premachandra ID, Scott KA, Shen C, Wang F, Lane S, Liu H, Van Vranken DL.

ChemMedChem. 2015 Oct;10(10):1672-86. doi: 10.1002/cmdc.201500271. Epub 2015 Aug 12.

6.

Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp.

Digirolamo JA, Li XC, Jacob MR, Clark AM, Ferreira D.

J Nat Prod. 2009 Aug;72(8):1524-8. doi: 10.1021/np900177m.

7.

Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.

Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF, Jiang YY.

Antimicrob Agents Chemother. 2006 Mar;50(3):1096-9.

8.

Fluconazole resistance in Candida albicans: a review of mechanisms.

Casalinuovo IA, Di Francesco P, Garaci E.

Eur Rev Med Pharmacol Sci. 2004 Mar-Apr;8(2):69-77. Review.

PMID:
15267120
9.

Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans.

Gamarra S, Rocha EM, Zhang YQ, Park S, Rao R, Perlin DS.

Antimicrob Agents Chemother. 2010 May;54(5):1753-61. doi: 10.1128/AAC.01728-09. Epub 2010 Mar 1.

10.

Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans.

Lo HJ, Tseng KY, Kao YY, Tsao MY, Lo HL, Yang YL.

Int J Antimicrob Agents. 2015 Jun;45(6):617-21. doi: 10.1016/j.ijantimicag.2015.01.017. Epub 2015 Mar 6.

PMID:
25802233
11.

Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans.

Liu H, Wang L, Li Y, Liu J, An M, Zhu S, Cao Y, Jiang Z, Zhao M, Cai Z, Dai L, Ni T, Liu W, Chen S, Wei C, Zang C, Tian S, Yang J, Wu C, Zhang D, Liu H, Jiang Y.

ChemMedChem. 2014 Jan;9(1):207-16. doi: 10.1002/cmdc.201300332. Epub 2013 Nov 4.

PMID:
24376206
12.

[Study on experimental induction of fluconazole resistance in Candida albicans].

Zhu YN, Lu SM.

Shi Yan Sheng Wu Xue Bao. 2004 Oct;37(5):418-22. Chinese.

PMID:
15636370
13.

The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.

Jin J, Guo N, Zhang J, Ding Y, Tang X, Liang J, Li L, Deng X, Yu L.

Lett Appl Microbiol. 2010 Sep;51(3):351-7. doi: 10.1111/j.1472-765X.2010.02900.x. Epub 2010 Jul 14.

14.

Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.

Li DD, Xu Y, Zhang DZ, Quan H, Mylonakis E, Hu DD, Li MB, Zhao LX, Zhu LH, Wang Y, Jiang YY.

Antimicrob Agents Chemother. 2013 Dec;57(12):6016-27. doi: 10.1128/AAC.00499-13. Epub 2013 Sep 23.

15.

Identification and characterization of antifungal compounds using a Saccharomyces cerevisiae reporter bioassay.

Tebbets B, Stewart D, Lawry S, Nett J, Nantel A, Andes D, Klein BS.

PLoS One. 2012;7(5):e36021. doi: 10.1371/journal.pone.0036021. Epub 2012 May 4.

16.
17.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
18.

Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.

Billack B, Santoro M, Lau-Cam C.

Microb Drug Resist. 2009 Jun;15(2):77-83. doi: 10.1089/mdr.2009.0872.

PMID:
19432523
19.

Ibuprofen potentiates the in vivo antifungal activity of fluconazole against Candida albicans murine infection.

Costa-de-Oliveira S, Miranda IM, Silva-Dias A, Silva AP, Rodrigues AG, Pina-Vaz C.

Antimicrob Agents Chemother. 2015 Jul;59(7):4289-92. doi: 10.1128/AAC.05056-14. Epub 2015 Apr 6.

20.

Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans.

Khodavandi A, Alizadeh F, Vanda NA, Karimi G, Chong PP.

Pharm Biol. 2014 Dec;52(12):1505-9. doi: 10.3109/13880209.2014.900808. Epub 2014 May 27.

PMID:
24863276

Supplemental Content

Support Center